Skip to main content

Day: November 7, 2023

Genmab Announces Financial Results for the First Nine Months of 2023

November 7, 2023 Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2023 HighlightsEpcoritamab (TEPKINLY®) was granted conditional marketing authorization by the European Commission (EC) to treat adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy Epcoritamab (EPKINLY™) was approved by the Japan Ministry of Health, Labour and Welfare to treat adults with certain types of relapsed or refractory large B-cell lymphoma (LBCL) after two or more lines of systemic therapy Genmab and Seagen Inc. (Seagen) announced that the Phase 3 innovaTV 301 confirmatory trial of tisotumab vedotin for the treatment of recurrent or metastatic cervical cancer met its primary endpoint of improved overall survival (OS) at a predetermined, independent interim...

Continue reading

Beam Global to Release Third Quarter 2023 Operating Results, Conference Call Scheduled for November 14, 2023 at 8:30 a.m. ET

SAN DIEGO, Nov. 07, 2023 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM, BEEMW), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy security, today announced that it will report its Third Quarter 2023 operating results on Tuesday November 14, 2023 before the market opens. Management will host a conference call on Tuesday November 14, 2023 at 8:30 a.m. ET to review financial results and provide an update on corporate developments. Following management’s formal remarks, there will be a question-and-answer session. Conference call details: Date: November 14, 2023Time: 8:30 a.m. Eastern / 5:30 a.m. PacificToll-Free Dial-In Number: 1-844-739-3880International Dial-In Number: 1-412-317-5716 Pre-register for the call through this link: https://dpregister.com/sreg/10184223/faffa0e023 All...

Continue reading

Global Quantum Computing for Enterprise Market Size USD 27,095.78 Million in 2032 | Emergen Research

Growing demand for simultaneous calculation of vast volume of data and rising need for optimal solutions to improve business value is driving quantum computing for enterprise market growth Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global quantum computing for enterprise market is forecast to reach a market size of USD 27,095.78  Million by 2032, with a steady reveunue growth rate, according to a current analysis by Emergen Research. Growing need for simultaneous calculation of vast data volume has been resulting in rapidly inclining demand for and deployment of these solutions, which is a major factor driving growth of the global quantum computing for the enterprise market. This trend is expected to continue to gain traction during the forecast period, thereby resulting steady increase in market size growth. In addition,...

Continue reading

Global Pet Food Packaging Market Size USD 16.07 Billion in 2032 | Emergen Research

The considerable demand for pet food led by increase in the rate of pet adoption and pet humanization in developing countries is driving the pet food packaging market Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global pet food packaging market is anticipated to reach value of USD 16.07 Billion by 2032, according to a current analysis by Emergen Research. The pet humanization trend is rising, as there is a more significant focus on wellness, health, sustainability, and transparency. Pet owners are willing to spend on pet food and products which are nutritious. The focus on pet welfare will soon become an intregral part of the big-box retailers in banning artificial products used in pet productsas the consumer prefer more health oriented and organic food for their pet, so in turn it will lead brands to make better quality pet...

Continue reading

ProVen VCT plc: Half-yearly report

PROVEN VCT PLC Half-yearly reportFor the six months ended 31 August 2023 ProVen VCT plc (“the Company”) is pleased to announce its interim results for the six months ended 31 August 2023. Financial Summary  31 August 2023 31 August 2022 28 February 2023Net asset value per share (“NAV”) 62.7p 67.6p 65.5pDividends paid per share since conversion/ consolidation* 82.75p 79.00p 80.75pTotal return (NAV plus dividends paid*) 145.45p 146.60p 146.25pNet assets (£’000) 162,513 161,785 161,740*Dividends paid represent dividends paid since the consolidation of 5p Ordinary Share into 10p Ordinary Shares on 30 October 2012. Prior to this date, the Company paid dividends totalling 113.95p on the 5p Ordinary Shares. Dividend The Board has declared an interim dividend of 1.5p per share which will be paid on 15 December 2023...

Continue reading

Global Medical Device Connectivity Market Size USD 17.31 Billion in 2032 | Emergen Research

Rising demand for data analytics solutions in the healthcare industry and growing emphasis on patient safety and quality of care are key factors driving medical device connectivity market growth Vancouver, Nov. 07, 2023 (GLOBE NEWSWIRE) — The global medical device connectivity market size reached USD 1.55 Billion in 2021 and is expected to register a CAGR of 24.5% during the forecast period, according to latest analysis by Emergen Research. Rising demand for data analytics solutions in the healthcare industry is a key factor expected to drive revenue growth of the global medical device connectivity market during the forecast period. Besides, rising emphasis on patient safety and quality of care is expected to further augment market growth. In addition, rising demand for telemedicine and telehealth applications in the healthcare...

Continue reading

Results of additional issuance – RIKB 28 1115 – RIKS 37 0115

As stated in paragraph 6 in General Terms of Auction for Treasury bonds, the Government Debt Management offered the equivalent of 10% of the nominal value sold in the auction 3. November, at the price of accepted bids.Series RIKB 28 1115 RIKS 37 0115ISIN IS0000028249 IS0000033793Additional issuance (nominal) 70,000,000 124,000,000Settlement date 11/08/2023 11/08/2023Total outstanding (nominal) 113,464,801,519 50,861,600,000

Continue reading

HealthEquity Named Top Workplace in Rankings Nationwide

Authentic culture and values recognized by teammates DRAPER, Utah, Nov. 07, 2023 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest health savings account (“HSA”) custodian, has been recognized as a Top Place to Work in nearly a dozen regional rankings around the country. The awards, which are based largely on workforce feedback, underscore HealthEquity’s commitment to foster a culture that empowers its team members. The company is recognized for its excellent performance in specific areas such as leadership, purpose, values, innovation, compensation, benefits, and work-life flexibility. “Our vision has always been to foster an environment where our team feels they belong, are able to grow professionally, and empowered to share their voice,” said Jon Kessler, President and CEO of HealthEquity....

Continue reading

Canadians can now bring home an elevated Asian restaurant experience with P.F. Chang’s Home Menu™ sauces and frozen meals

P.F. Chang’s Home Menu™ sauces and frozen mealsP.F. Chang’s Home Menu™ sauces and frozen mealsMISSISSAUGA, Ontario, Nov. 07, 2023 (GLOBE NEWSWIRE) — Canadians who want an elevated dining experience at home can now enjoy the bold, restaurant-inspired flavours of P.F. Chang’s™, the number one Asian casual dining restaurant in the United States.1 Canadians can now find P.F. Chang’s Home Menu™ sauces and frozen single-serve and multi-serve frozen meals at their favourite grocery retailer, providing them restaurant quality flavours at home. Co-developed with P.F. Chang’s™ restaurants and their chefs, P.F. Chang’s Home Menu™ products are made with premium ingredients and bold flavours with a line-up that includes:Four versatile and delicious sauces prepared in Canada: Sesame, Teriyaki,...

Continue reading

Ferrari N.V.: Announcement of the Fourth Tranche of the Multi-Year Share Repurchase Program

Maranello (Italy), November 7, 2023 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) announces its intention to continue its multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day, with a fourth tranche of up to Euro 350 million to start on November 8, 2023 (“Fourth Tranche”) and to end no later than June 26, 2024 with two components:Firstly, Ferrari has entered into a non-discretionary buyback agreement for an amount up to Euro 250 million to be executed on the EXM market through a primary financial institution (the “Bank”). The Bank will make its trading decisions concerning the timing of the purchases of Ferrari’s common shares independently of and uninfluenced by Ferrari and it will act in compliance with applicable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.